Protecting Axons Protecting Patients Creating breakthrough therapeutics for neurological diseases learn more SARM1 Deletion Protects Axons in a Model of Inflammatory Demyelination September 11, 2019 poster + Disarm Therapeutics Announces First Subject Enrolled in EPIPHANY Natural History Study of Chemotherapy-Induced Peripheral Neuropathy (CIPN) September 4, 2019 press release + A New Approach to Treating Multiple Sclerosis News +
